“As soon as the Government announce details of the selection process and requirements, we will be applying,” founder and CEO Leonora O'Brien said.

“Our vaccination system has been in development since the beginning of the pandemic and we are working alongside partners such as the International Pharmaceutical Federation to bring it through the final stages.” 

Ms O’’Brien said the system will essentially “streamline the end-to-end process for patients and those administrating the vaccine.” 

“This will allow the public to easily book their vaccine via any device, schedule multiple doses, complete their eligibility criteria and provide details of any side-effects that have occurred. The data will flow securely from patient to administrator to national stakeholders and governmental organisations.” 

Public health authorities will also be able to receive real time, anonymous information about how the vaccine rollout is working, she explained.

“By simplifying the entire process, the solution promotes vaccine uptake, minimises the time required to administer each vaccine and provides critical data on side-effects so that corrective actions may be put in place as required."

Pharmapod currently provides a number of cloud-based, healthcare specific solutions for pharmacies, hospitals and the Long-Term Care sector and delivers vaccination services such as flu vaccines.

Its systems are used in the United States, the UK, Canada, Australia, New Zealand and Ireland.